| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Shanghai Haohai Biological Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$43.20 |
| 52 Week High | HK$50.20 |
| 52 Week Low | HK$30.30 |
| Beta | 0.80 |
| 1 Month Change | 13.68% |
| 3 Month Change | 17.39% |
| 1 Year Change | 12.50% |
| 3 Year Change | -40.08% |
| 5 Year Change | -5.05% |
| Change since IPO | -26.03% |
Recent News & Updates
Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17
Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?
Feb 12Recent updates
Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?
Feb 12Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 30Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price
May 08Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Apr 19Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Mar 04Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 03Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?
Jan 10Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Oct 08Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly
Jul 07Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%
May 27These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Apr 04Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%
Mar 16Can Mixed Fundamentals Have A Negative Impact on Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Current Share Price Momentum?
Feb 23What Type Of Shareholders Own The Most Number of Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Shares?
Feb 05
Does Shanghai Haohai Biological Technology's (HKG:6826) Statutory Profit Adequately Reflect Its Underlying Profit?
Jan 21Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Should Think About This Before Buying It For Its Dividend
Jan 06We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Dec 22What Does Shanghai Haohai Biological Technology's (HKG:6826) CEO Pay Reveal?
Dec 07Is The Market Rewarding Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Nov 24Shareholder Returns
| 6826 | HK Biotechs | HK Market | |
|---|---|---|---|
| 7D | 2.1% | -3.1% | 1.3% |
| 1Y | 12.5% | -33.9% | 1.6% |
Return vs Industry: 6826 exceeded the Hong Kong Biotechs industry which returned -33.9% over the past year.
Return vs Market: 6826 exceeded the Hong Kong Market which returned 1.6% over the past year.
Price Volatility
| 6826 volatility | |
|---|---|
| 6826 Average Weekly Movement | 4.9% |
| Biotechs Industry Average Movement | 9.5% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in HK Market | 15.7% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 6826 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6826's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 2,158 | Jianying Wu | www.3healthcare.com |
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products comprising intraocular lens, ophthalmic viscoelastic devices, orthokeratology and phakic refractive lenses, eye drops, soft contact lens, medical sodium hyaluronate gels, injectors, scalpels, suture needles, and other products; orthopedics products, such as sodium hyaluronate injection and medical chitosan products; and anti-adhesion products, including medical sodium hyaluronate gel, and medical chitosan and collagen sponge products.
Shanghai Haohai Biological Technology Co., Ltd. Fundamentals Summary
| 6826 fundamental statistics | |
|---|---|
| Market cap | HK$15.16b |
| Earnings (TTM) | HK$466.32m |
| Revenue (TTM) | HK$2.90b |
15.6x
P/E Ratio2.5x
P/S RatioIs 6826 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6826 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.69b |
| Cost of Revenue | CN¥821.59m |
| Gross Profit | CN¥1.87b |
| Other Expenses | CN¥1.43b |
| Earnings | CN¥432.49m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.57 |
| Gross Margin | 69.44% |
| Net Profit Margin | 16.08% |
| Debt/Equity Ratio | 6.4% |
How did 6826 perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield39%
Payout RatioDoes 6826 pay a reliable dividends?
See 6826 dividend history and benchmarks| Shanghai Haohai Biological Technology dividend dates | |
|---|---|
| Ex Dividend Date | Jun 06 2024 |
| Dividend Pay Date | Jul 19 2024 |
| Days until Ex dividend | 14 days |
| Days until Dividend pay date | 57 days |
Does 6826 pay a reliable dividends?
See 6826 dividend history and benchmarks